Try our Advanced Search for more refined results
Life Sciences - July, 2008
172 articles
- FDA Orders Stronger Warn Labels For Anemia Drugs
- Abraxis Fails To Nix Naropin Suit Antitrust Claims
- Abbott Settles HIV Antitrust Suit With Indirect Buyers
- Ariz. Court Validates Bard's Graft Patent
- Sepracor Suits Over Planned Generic Xyzal Pile Up
- 2nd Circ. Cuts NYSE Traders Loose
- Judge Knocks Down Schwarz's Claims In Miralex Case
- FDA Warns Baxter On Hemophilia Drug Promotion
- AstraZeneca Files 5th Suit Over Generic Seroquel
- Class Certification Denied In Express Scripts Suit
- Teva Settles Coreg Suit Against Dr. Reddy's
- Fed. Circ. Sides With Sanofi In Patent Spat With Novo
- FDA Seizes $24M In Unapproved Drugs From KV
- Buchanan Ingersoll Disqualified From Ritalin Suit
- Riegel V. Medtronic: Better Off Without It?
- Drug Cos. Win Big With Pass-On Defense
- Judge OKs Nellson's Disclosure Statement
- German Court OKs Generic Plavix, Cos. To Appeal
- Endo Hits Impax With 3rd Suit Over Painkiller
- Judge Rejects New Notice For Digitek Patients
- Melnyk Drops Biovail Proxy Bid, For Now
- LecTec Sticks J&J, Others With Medical Patch Suit
- Seven Patents Dropped From GE Patent Battle
- Judge Tosses Preempted Claims From Aredia Suits
- Stent Inventor Sues Abbott For Infringement
- Payout Rates Slashed For Litigators In Medtronic MDL
- 2nd Circ. Affirms FDA Injunction Decision
- EU Product Liability Directive's Statute Of Limitations
- Novartis Sues Teva Over Premature ANDA Letters
- Lawyers In Guidant Case Ask For Higher Fee
- PRP Breached Duty To Verex Shareholders: Jury
- Shire Sues Actavis Over Carbatrol ANDA
- Opponents Of Gene Patents Fight On
- Judge Dismisses Ortho-McNeil From One AWP Claim
- Patent Injunctions After EBay
- Judge Cites Cert Grant In Keeping Lexapro Cases Alive
- Biovail Dodges Antitrust Class Actions Over Tiazac
- FTC Launches Formal Investigation Into Immucor
- Cephalon Sues Barr Over Generic Fentora
- AstraZeneca Sues Mylan Over Entocort ANDA
- Employment Practice: Jones Day
- Feds Seize Erectile Dysfunction Drugs
- Lawyers Debate Value Of 'Lone Pine' Orders
- Regulatory And Govt. Affairs Practice: WilmerHale
- Shareholder Sues Roche, Genentech Over $43.7B Deal
- State Courts Embrace On-Camera Culture
- Suit Alleges Teva's Pergolide Damaged Heart Valves
- On Biotech Hot Streak, Roche Picks Up Arius
- Amerigroup Settles Discrimination Suit For $234M
- Sanofi Can't Subpoena Employers In Gender Suit
- Hire Sheet: Law Firms Hired For Major IP Litigation
- GSK Snags Former FDA General Counsel Dan Troy
- Regulators Conclude Merck's Gardasil Is Safe
- USPTO Asks Fed. Circ. To Reverse Ruling In Tafas Case
- Judge Rejects KV Sanctions Bid In Ritalin ANDA Suit
- Baxter Wins Judgment In Failure-To-Warn Case
- Portable Ultrasound Makers Settle Patent Dispute
- Impax's Flomax ANDA Triggers Patent Suit
- FDA Warns Anika About 'Adulterated' Devices
- New Study Adds Vytorin Woes For Merck, Schering
- Hire Sheet: Law Firms Hired For Major IP Litigation
- Regulatory Practice: Fish & Richardson
- Biota, GSK Settle Relenza Marketing Suit For $19.5M
- Boston, Medtronic Agree To Slash Damages By $64M
- Regulators To Take Close Look At Big Pharma Deals
- Fed. Circ. Upholds Eisai's Aciphex Patent
- W.L. Gore Says Medtronic Patents Are Invalid
- Leiner Files Plan With Committee's OK
- Paxil Preemption Ruling Reversed In Indiana
- KV Sues Breckenridge Over Supplement Patent
- Product Liability Practice: DLA Piper
- Jury Clears J&J, Motrin For Girl's Blindness
- Ortho V. Mylan: Key Ruling For 2 Statutory Provisions
- House To Probe FDA Knowledge Of Ranbaxy Fraud
- Merck's Vioxx Payouts To Begin In August
- View Of Swamped USPTO Cutting Corners Challenged
- Wyeth Reverses Course, Settles Prempro Suit
- Sanofi Stalls Generic Plavix Launch In Germany
- Advanced Bionics Pays $1.1M To Settle With FDA
- New Mexico Rebuked Over Discovery In Zyprexa Case
- S.C. Mayor Settles Insider Trading Suit With SEC
- Wyeth, Impax Settle Effexor Patent Dispute
- DEA's New Proposed Regulations For E-Prescribing
- IP Practice: Akin Gump
- Fenwick Life Sciences Partner Jumps To Reed Smith
- Hire Sheet: Law Firms Hired For Major IP Litigation
- Judge Orders New Biovail Shareholder Meeting
- Health Practice: Hogan & Hartson
- SmithKline Beecham Sued For Generic Flonase Delay
- Hire Sheet: Law Firms Hired For Major IP Litigation
- IP Practice: WilmerHale
- Katten Hires Former Ev3 Patent Counsel
- Cos. Settle Dutch Probe Into Oil-For-Food For €1.3M
- Fed. Circ. Rules Apotex's Fosamax Appeal Moot
- N.J. Packagers Are Link In Acutrim Liability Chain
- Post-KSR Case Law: The Sky Is Not Falling
- FDA Warns Avastin May Cause Anemia
- Judge Gives Biotech Co. Shareholders 2nd Chance
- Fed. Circuit Remands Stent Case Over 'Ambiguity'
- Wilson Sonsini Adds Veteran Litigator In New York
- Abbott, Hospira To Face Trial In ERISA Class Action
- By-Pass Sues Abbott Over Vascular Repair Patent
- New Study Hints At More Fosamax Problems
- Hire Sheet: Law Firms Hired For Major IP Litigation
- AstraZeneca Files Ninth Suit Over Crestor Patent
- Sides Bicker Over Bifurcation In Mirapex Case
- Judge Partly Reverses $250M Verdict For Medtronic
- Hire Sheet: Law Firms Hired For Major IP Litigation
- IP Practice: Hogan & Hartson
- Firm Wants Higher Contingency Fee In Guidant MDL
- Judge Finalizes Last Warner Chilcott Settlement
- N.J. Court Dismisses Hormone Therapy Lawsuit
- Ranbaxy Denies DOJ Allegations Over Audits
- Amgen Agrees To $200M Settlement Of Antitrust Suit
- Cases Added To MDL Over Tainted Heparin
- Hire Sheet: Law Firms Hired For Major IP Litigation
- Actavis Hit With Class Action Over Digitek
- Transkaryotic Ex-CEO Settles SEC Suit For $1.2M
- Forklift Operator Avoids Jail In Insider Trading Scam
- Emergent Sues Protein Sciences Over Failed Deal
- Roche, Ranbaxy Patent Fight Can Go To Trial
- The Last Word On Drug Preemption?
- Pharmaceutical Industry Revises Code Of Conduct
- Corepharma Counterclaim Restored To Carbatrol Suit
- Abbott Labs Strikes Again Over Depakote ER
- House Of Lords Validates Angiotech's Stent Patent
- M&A Practice: Duane Morris
- Health Practice: McDermott, Will & Emery
- Suit Claims Botox Caused Injuries, Deaths
- Apotex Acular ANDA Infringes Roche: Fed. Circ.
- Biolitec Attacks VNUS' Laser Treatment Patents
- IP Practice: White & Case
- Judge Lifts Stay Of Counterclaims In Ofloxacin Case
- Boston Scientific Bid For New Stent Trial Rejected
- Pfizer Forgoes Fees To Close Accupril Suit
- Judge Tosses $27M Award In Prempro Case
- Celgene Sues Barr Again Over Cancer Drug
- No Proven Links Between Eczema Drug, Cancer: Judge
- Bristol-Myers Agrees To Clean Air Act Upgrades
- Abbott Loses Appeal Bid In HIV Drug Litigation
- Molecular Samples Tester Sued Over Assay Patents
- Pillsbury Lures Partner From Schulte Roth
- Anheuser Takes InBev To Court Over Takeover Bid
- Karl Storz Sues FemSuite Over Endoscope Patent
- FDA Urges Warning For Cipro, Other Antimicrobials
- Competition Practice: McDermott Will & Emery
- InBev Moves To Dislodge Anheuser Board
- Shire Sues Apotex, Nostrum Over Carbatrol ANDAs
- Judge Inclined To OK Zyprexa Class, Urges Settling
- 3rd Circuit Affirms Dismissal Of Savient Class Action
- VNUS Sues Three More Rivals Over Laser Treatment
- Eli Lilly Drops Glenmark In $500M ADHD Drug Suit
- Pfizer Employee Avoids Prison in Embezzlement Case
- Panel Recommends More Testing for Diabetes Drugs
- Time For A New Look At Antitrust Penalties
- Daiichi Sankyo's Patent Suits V. Mylan Combined
- The Shifting Landscape Of Declaratory Judgment Law
- Sheppard Adds Two IP Litigators To Its Ranks
- Bone Fusing Products Pose Risk, FDA Says
- Jury Lets One Fen-Phen Lawyer Off The Hook
- Pfizer Wins Dismissal Of 4 Claims From Celebrex Suit
- IP Practice: Holland & Knight
- Drugmakers To Appeal $114M Verdict In AWP Case
- Inequitable Conduct Claim Nixed In Seroquel Suit
- Plaintiffs Battle For Lead Role In Vytorin ERISA Suit
- VA Official Pleads Guilty To Accepting Kickbacks
- Iraq Sues 93 Over Oil-For-Food Corruption
- Biotech Cos. Battle Over Forum In Stem Cells Suit
- AstraZeneca Sues To Protect Accolate
- Bavarian Nordic Sues Oxford BioMedica Over Patents
- Patent Litigator Leaves Latham For Kaye Scholer
- CORRECTED: Cardio Access Expands Catheter Patent Suit